Tag: U.S. Pharmaceutical Market
Lupin Announces U.S. FDA Approval and Launch of Sugammadex Injection
Lupin Limited announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA)...
Glenmark Launches Generic Methylene Blue Injection in the U.S.
Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the official launch of Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) Single-Dose Vial. Glenmark’s new generic...
